Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY

No-Receipt date 2025-01995 - 12/06/2025
No-Filing date 20250401189 - 12/06/2025
No-Granting date 3118421 - 20/06/2025
No-EPO application date 20829249.0 - 03/12/2020
No-EPO granting date 4069237 - 09/04/2025
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 6/2025 - 07/07/2025
Expiration date 04/12/2040
Kind of title Validation of European Patent
Legal status VALID
Priorities US201962943720 P04/12/2019/US
US202063010524 P15/04/2020/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/497
A61K 31/5377
A61P 35/00
A61P 37/00

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1746945 NURIX THERAPEUTICS, INC. 1700 OWENS STREET SUITE 205SAN FRANCISCO, CA 94158 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
4586738 SANDS, ARTHUR T.
4586739 KELLY, AILEEN

Representatives
CodeFirstnameSurnameAddressTownZip
3098ANNAGIAKOUMIALKAMENOUS 12-14ATHINA (ATTIKIS)10439

Contact
CodeFirstnameSurnameAddressTownZipCountry
8397ANDRONIKIMISIOUANALIPSEOS 23 KAI MARATHONOS 27VRILISSIA (ATTIKIS)15235 GREECE

Owners History

Title Instruments

Payments history 5 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015